# Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Study · id `cardio:ct-nct06479343` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06479343](<https://clinicaltrials.gov/study/NCT06479343>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06479343

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

## Technical summary

Registry record NCT06479343. Randomized; no masking; primary purpose treatment. Start 2024-06-27 (actual); primary completion 2025-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 170 participants (planned count; ClinicalTrials.gov record NCT06479343, source copy `cardio:ctgov-nct06479343-2024-09-19`, retrieved 2026-11-18)
- Started: 2024-06-27 (actual) (ClinicalTrials.gov record NCT06479343, source copy `cardio:ctgov-nct06479343-2024-09-19`, retrieved 2026-11-18)
- Primary completion: 2025-10 (anticipated) (ClinicalTrials.gov record NCT06479343, source copy `cardio:ctgov-nct06479343-2024-09-19`, retrieved 2026-11-18)
- Completion: 2026-10 (anticipated) (ClinicalTrials.gov record NCT06479343, source copy `cardio:ctgov-nct06479343-2024-09-19`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06479343, source copy `cardio:ctgov-nct06479343-2024-09-19`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06479343-2024-09-19`, retrieved 2026-11-18)

## The registry's words

- Brief title: Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations
- Condition: Intracranial Arteriovenous Malformations
- Intervention (Device): Liquid Embolic System (Tonbridge)
- Intervention (Device): Onyx Liquid Embolic System (Medtronic)
- Lead sponsor: Ton-Bridge Medical Tech. Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arteriovenous malformation (AVM) (`cardio:arteriovenous-malformation`)
- Registry lists this organization as the lead sponsor: Ton-Bridge Medical Tech. Co., Ltd (`cardio:org-ton-bridge-medical-tech-co-ltd`)

## Provenance

Content hash: 8642445a8b5d3a8da34d84b0545f5c08ffae152c7bdb9a8bbd1d8dd88520ebc8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
